More MS news articles for Aug 2001

Many Drugs Harm the Liver, but Most Remain on the Market

http://www.nytimes.com/2001/08/14/health/anatomy/14LIVE.html?searchpv=day05

August 14, 2001
By LAURIE TARKAN

It is an unsettling truth, one that people who have to take medicine would probably rather not think about: occasionally, with little or no warning, prescription and even over-the-counter drugs can cause liver damage. Cases are not common, but they can be devastating, leading to death or requiring a transplant.

"Drug-induced liver disease is probably the single leading cause of drugs' running afoul once they hit the market," said Dr. Peter K. Honig, director of the Office of Postmarketing Drug Risk Assessment at the Food and Drug Administration.

Liver failure, also called hepatotoxicity, is rare, affecting about 2,000 adults and 90 children a year in the United States. But drugs cause about 55 percent of the liver failure cases evaluated at liver transplant centers, said Dr. William M. Lee of the University of Texas Southwestern Medical Center in Dallas, who runs a group that surveys about 40 of the centers. But in addition to cases of irreversible liver failure are many more instances of less serious liver damage that are not recorded, experts say.

Liver problems and deaths have led to several drugs' being taken off the market in the last few years, and to others' having warnings added to their labels. The problems can be a tremendous drain on drug companies, which may be hit with lawsuits and forced to withdraw drugs they spent hundreds of millions of dollars to develop.

In the last year, the F.D.A. has increased its efforts to prevent the problems. It has held drug toxicity workshops for staff members who review new drug applications. It is also working with liver experts, and it held a conference in February with them and the drug industry to develop better ways to identify potentially toxic drugs and spot problems once a drug is approved. The proceedings of that conference were posted on the F.D.A.'s Web site, www.fda.gov.

The agency's actions were prompted in part by an unusually high number of drugs that were found to cause liver failure in the past few years.

Most notably, the popular diabetes drug Rezulin, approved in 1997, caused about 90 cases of liver failure, including 63 deaths, before it was withdrawn in March 2000.

A year earlier, the antibiotic Trovan was severely restricted after 14 cases of acute liver failure were reported, and the year before that, a painkiller called Duract was withdrawn after causing four deaths and necessitating eight liver transplants.

Dr. Neil Kaplowitz, director of the University of Southern California Center for Liver Diseases, said: "The problem of drugs causing injury to the liver has been recognized probably for 50 years. But the attention that has been focused on Rezulin has put the spotlight on it."

More cases are brought on by acetaminophen, the ingredient in Tylenol and many other products used for pain and fever. Each year it causes acute liver failure in nearly 800 people who take more than the recommended dose (including those who intentionally take an overdose). Most recover; in 1999, 85 died.

The F.D.A. is also looking into how to reduce the risk of liver toxicity from acetaminophen, said Dr. Robert Temple, the associate director for medical policy for the drug evaluation and research center of the F.D.A.

Children are as susceptible to liver injury as adults, although the incidence is lower in children because they take fewer medications.

The liver is particularly vulnerable to drugs because one of its functions is to break down or metabolize chemicals that are not water soluble. Most drugs fit that description.

"The liver has a machinery of enzymes that converts drugs into more water-soluble forms that can then be excreted," Dr. Kaplowitz said. But, he added, sometimes the breakdown products are toxic to liver cells.

Normally, the liver detoxifies these poisons before they can harm it. Indeed it is surprising, given the noxious chemicals that the liver is exposed to, that more drugs do not damage it.

"It's a tribute to the fact that the liver has an incredible capacity to defend itself," Dr. Kaplowitz said.

But in a few people, something goes awry. Either the liver churns out excessive toxins, or its ability to get rid of them is impaired. The toxins in turn destroy liver cells. While a majority of cases are mild to moderate, in about 10 percent of people the reaction is severe, resulting in coma, multiple organ failure and death, Dr. Kaplowitz said.

The fact that liver damage from drugs is rare and random is what makes it difficult to prevent. Acetaminophen, in fact, is the only common drug for which toxicity is predictable and therefore preventable. When taken at a high enough dose, it will cause liver toxicity in everybody. Taking more than the recommended daily dose overloads the liver and causes it to begin using an enzyme, cytochrome p450, that breaks down acetaminophen into toxins.

The maximum dose of acetaminophen for adults is 4,000 milligrams a day, or eight extra-strength tablets. Children's doses are much smaller, and vary by weight and age; a 4-year-old, for instance, should never be given more than 1,200 milligrams a day.

Adults who are chronic drinkers (having three or more drinks a day) risk liver injury if they take more than 2,000 milligrams a day. Chronic drinking raises background levels of cytochrome p450 in the liver, so that when a drinker also takes acetaminophen, more of the drug is metabolized into toxins than in nondrinkers.

The reason adults die from acetaminophen poisoning is that many perceive the drug as safe and take too much, or do not consider themselves chronic drinkers.

In children, problems occur when they are given the drug too often, or in adult doses, or for too many days, which may cause the drug to build up.

"If a child has a fever longer than 24 to 36 hours requiring 4-hour to 6-hour dosing of Tylenol, talk to your doctor to make sure the child doesn't have a more serious illness, and for help with dosing properly," said Dr. Rob Squires, an expert in pediatric hepatotoxicity at the University of Texas Southwestern Medical Center.

The American Liver Foundation believes the current warnings on acetaminophen labels do not adequately convey the risk to the liver.

With most other drugs, however, liver injury is unpredictable and therefore more difficult to prevent. A vast majority of people can take potentially harmful drugs without any problem, as was the case with the 1.5 million who took Rezulin. But a very small percentage 1 in 10,000, or even fewer will have a serious liver injury. Experts theorize that these people may be genetically predisposed to liver toxicity.
 

Copyright 2001 The New York Times Company